Kamal S Pohar MD


Kamal S Pohar MD
Assoc ProfessorCollege of Medicinepohar.1@osu.edu
Olentangy River Road 915 915 Olentangy River Road Columbus Ohio 43212
Phone:614-293-4885Fax: 614-293-3565
  • Molecular Biology and Cancer Genetics

Current Publications

  • Knopp MVImproving Bladder Cancer Imaging Using 3-T Functional Dynamic Contrast-Enhanced Magnetic Resonance Imaging.Invest Radiol 3/14/2014
  • Perrino CM, Fichtenbaum EJ, Pohar KS, Zynger DLChallenges in the pathological reporting of urothelial carcinoma involving prostatic transurethral resection specimens within a single institution.Pathology 45 664-9 12/1/2013
  • D'Souza AM, Phillips GS, Pohar KS, Zynger DLClinicopathologic characteristics and overall survival in patients with bladder cancer involving the gastrointestinal tract.Virchows Arch in press 10/4/2013
  • Pohar KSThe anatomic extent and completeness of pelvic lymphadenectomy is what matters.Curr Opin Urol 23(5) 444-8 9/1/2013
  • Clark PE, Spiess PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro L, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Trump DL, Wile G, Wilson TG, Dwyer M, Ho MPenile cancer: Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw 11(5) 594-615 5/1/2013
  • Clark PE, Agarwal N, Biagioli MC, Eisenberger MA, Greenberg RE, Herr HW, Inman BA, Kuban DA, Kuzel TM, Lele SM, Michalski J, Pagliaro LC, Pal SK, Patterson A, Plimack ER, Pohar KS, Porter MP, Richie JP, Sexton WJ, Shipley WU, Small EJ, Spiess PE, Trump DL, Wile G, Wilson TG, Dwyer M, Ho MBladder cancer.J Natl Compr Canc Netw 11(4) 446-75 4/1/2013
  • D'Souza AM, Pohar KS, Arif T, Geyer S, Zynger DLRetrospective analysis of survival in muscle-invasive bladder cancer: impact of pT classification, node status, lymphovascular invasion, and neoadjuvant chemotherapy.Virchows Arch 461(4) 467-74 10/1/2012
  • Korytko TP, Lowe GJ, Jimenez RE, Pohar KS, Martin DDProstate-specific antigen response after definitive radiotherapy for Skene's gland adenocarcinoma resembling prostate adenocarcinoma.Urol Oncol 30(5) 602-6 9/1/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu